Nicoletta Muner of Clinuvel Pharmaceuticals Ltd. joined us for World Orphan Drug Congress USA 2015 to present about ‘ SCENESSE® :Commercialization of a First-In-Class NCE’
Download her presentation now to understand more about:
- Scenesse Clincial Program
- Erythropoietic Protoporphyria (EPP)
- EPP Clinical Development and Expanded Access
- EMA Evaluation (Centralised Procedur)
…and much more!
Get your copy here!
To find out more about SCENESSE® , attend World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.